Catalog No.
PHJ36001
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human HGD (Ser8-Gly205).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
Homogentisate 1,2-dioxygenase,Homogentisicase,HGO,HGD,Homogentisate oxygenase,Homogentisic acid oxidase
Purification
Purified by antigen affinity column.
Accession
Q93099
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Performance evaluation of the access anti-HBc IgM Assay on the DxI 9000 access immunoassay analyzer., PMID:40305958
Advancing Non-Invasive Colorectal Cancer Screening: Exploring the Potential of Monoclonal Antibody L2A5., PMID:40243708
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study., PMID:39773564
ROLE OF IMMUNOHISTOCHEMICAL EXPRESSION OF D2-40 MARKER IN HIGH-GRADE DYSPLASIA, MICROINVASIVE AND FRANKLY INVASIVE ORAL SQUAMOUS CELL CARCINOMA., PMID:39623817
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial., PMID:39515198
The Innate Immune System Surveillance Biomarker p87 in African Americans and Caucasians with Small High-Grade Dysplastic Adenoma [SHiGDA] and Right-Sided JAK3 Colon Mutations May Explain the Presence of Multiple Cancers Revealing an Important Minority of Patients with JAK3 Mutations and Colorectal Neoplasia., PMID:39507544
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial., PMID:37491373
Bovine meat and milk factor protein expression in tumor-free mucosa of colorectal cancer patients coincides with macrophages and might interfere with patient survival., PMID:36811271
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study., PMID:35960332
Structural diversity of the SARS-CoV-2 Omicron spike., PMID:35447081
Clinical Utility of the Signal-to-Cutoff Ratio of Reactive HIV Antigen/Antibody Screening Tests in Guiding Emergency Physician Management., PMID:35147582
p53 expression in repair/reactive renal tubular cells: A potential pitfall leading to a false-positive diagnosis of urine cytology., PMID:34783171
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies., PMID:34242577
Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts., PMID:33541830
Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration., PMID:33202105
Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy., PMID:32983143
Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas., PMID:32541631
Non-invasive urinary sediment double-immunostaining predicts BK polyomavirus associated-nephropathy in kidney transplant recipients., PMID:32309382
Assessment of Thyroid Function in Patients With Alkaptonuria., PMID:32202644
[Cryoglobulin and factors associated with it in patient with anti-hepatitis-C antibodies living in resource-limited countries]., PMID:31565130
Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application., PMID:30974945
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity., PMID:29599246
Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies., PMID:29216196
Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia., PMID:29152066
The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker., PMID:28157706
Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus., PMID:27941559
Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps., PMID:27567189
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes., PMID:27454006
A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus., PMID:27197290
[Prevalence of altered mismatch repair protein nuclear expression detected by immunohistochemistry on adenomas with high-grade dysplasia and features associated with this risk in a population-based study]., PMID:26790715
Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm., PMID:26408423
Dysplasia-like epithelial atypia in ischemic bowel disease., PMID:24946975
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination., PMID:24648342
MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas., PMID:24280573
Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis., PMID:23466464
MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors., PMID:23112547
Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer., PMID:21969570
Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations., PMID:21710645
Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis., PMID:21509910
Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies., PMID:21359892
Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE)., PMID:21157443
Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma., PMID:20731025
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair., PMID:20501833
Altered expression of CD44 and DKK1 in the progression of Barrett's esophagus to esophageal adenocarcinoma., PMID:19396460
Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions., PMID:18641004
Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment., PMID:18383889
Difference in cell proliferation between two structurally different lesions in colorectal adenomas: high-grade dysplasia and carcinoma in situ., PMID:18214039
Expression pattern of squamous cell carcinoma antigen in oesophageal dysplasia and squamous cell carcinoma., PMID:17523076
Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma., PMID:17394006
Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus., PMID:16949933
For research use only. Not for human or drug use.
